Welcome to our dedicated page for DOCGO SEC filings (Ticker: DCGO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing DocGo’s multi-segment disclosures can feel like treating a patient without a chart. The company’s mobile health contracts, ambulance fleet costs, and virtual-care metrics often sit side-by-side in a single document. Whether you’re hunting for how a new city contract shows up in an 8-K or comparing Mobile Health margins across quarters, the details are deep. That’s why investors search for "DocGo SEC filings explained simply"—and why Stock Titan starts by translating the technical language.
Our AI reads every 10-K, 10-Q, 8-K, and Form 4 the moment it hits EDGAR. Within seconds you’ll see
- AI-powered summaries that surface segment revenue, payer mix, and fleet expansion costs
- Real-time alerts on "DocGo Form 4 insider transactions real-time" for fast trade monitoring
- Expert notes that turn complex healthcare reimbursement tables into plain English
Investors routinely ask about "DocGo insider trading Form 4 transactions" and "DocGo proxy statement executive compensation" to gauge management’s incentives. Others want the "DocGo annual report 10-K simplified" or "DocGo 8-K material events explained" to understand how new municipal deployments could shift revenue. By "understanding DocGo SEC documents with AI," you’ll pinpoint which units drive growth, track "DocGo executive stock transactions Form 4," and monitor cash burn tied to ambulance acquisitions—information that can influence valuation well before the next earnings call.
Stephen K. Klasko, a director of DocGo Inc. (DCGO), was granted 100,000 restricted stock units (RSUs) under the Issuer's 2021 Stock Incentive Plan. Each RSU represents the right to receive one share of DocGo common stock upon vesting.
The RSUs vest on September 10, 2026 subject to the terms of the plan. The reported grant carried a $0 per-share price and, after the grant, Mr. Klasko is reported to beneficially own 115,000 shares. The Form 4 was submitted by an attorney-in-fact on behalf of the reporting person.
FAQ
What is the current stock price of DOCGO (DCGO)?
What is the market cap of DOCGO (DCGO)?
